Literature DB >> 11381371

Increased D allele frequency of the angiotensin-converting enzyme gene in pulmonary fibrosis.

C D Morrison1, A C Papp, A Q Hejmanowski, V M Addis, T W Prior.   

Abstract

An insertion/deletion (I/D) polymorphism of the angiotensin-converting enzyme has previously been studied extensively in relationship to cardiovascular and renal disease. The deletion/deletion (D/D) genotype is associated with a poor outcome in immunoglobulin (Ig) A nephropathy. However, the association of this genetic marker in cardiovascular and renal disease has generated controversy, with the exception of the rate of progression and therapeutic responsiveness in IgA nephropathy. Many of the same cytokines and polypeptide mediators involved in fibrosis of the cardiovascular and renal systems have been shown to be involved in pulmonary fibrosis. We examined the I/D polymorphism of the angiotensin-converting enzyme in a group of 24 patents with interstitial pneumonia and moderate to severe pulmonary fibrosis defined by radiographic studies, pulmonary function tests, and histologic findings. The incidence of the D allele in this study population was 69.0%, which is approximately 15.0% higher than the incidence in the general population of 54.0%. The incidence of the D/D genotype was 42.0%, which is approximately 11.0% greater than that in the general population (31.0%). The distribution of the D/D, I/D, and insertion/insertion genotypes of these 24 patients was not significantly different from that of historical controls (P =.1; chi(2) test); there were marginally significantly more D alleles among the 48 observed alleles than would be expected (P =.04).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11381371     DOI: 10.1053/hupa.2001.24321

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  17 in total

1.  Angiotensin-converting enzyme (ACE) gene polymorphisms are associated with idiopathic pulmonary fibrosis.

Authors:  Soo-Taek Uh; Tae-Hoon Kim; Eun-Young Shim; An-Soo Jang; Sung-Woo Park; Jong-Sook Park; Byung-Lae Park; Byoung Whui Choi; Hyoung Doo Shin; Dong Soon Kim; Choon-Sik Park
Journal:  Lung       Date:  2013-05-09       Impact factor: 2.584

2.  An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.

Authors:  Ganesh Raghu; Harold R Collard; Jim J Egan; Fernando J Martinez; Juergen Behr; Kevin K Brown; Thomas V Colby; Jean-François Cordier; Kevin R Flaherty; Joseph A Lasky; David A Lynch; Jay H Ryu; Jeffrey J Swigris; Athol U Wells; Julio Ancochea; Demosthenes Bouros; Carlos Carvalho; Ulrich Costabel; Masahito Ebina; David M Hansell; Takeshi Johkoh; Dong Soon Kim; Talmadge E King; Yasuhiro Kondoh; Jeffrey Myers; Nestor L Müller; Andrew G Nicholson; Luca Richeldi; Moisés Selman; Rosalind F Dudden; Barbara S Griss; Shandra L Protzko; Holger J Schünemann
Journal:  Am J Respir Crit Care Med       Date:  2011-03-15       Impact factor: 21.405

Review 3.  The genetic approach in pulmonary fibrosis: can it provide clues to this complex disease?

Authors:  William E Lawson; James E Loyd
Journal:  Proc Am Thorac Soc       Date:  2006-06

4.  Association of angiotensin-converting enzyme insertion/deletion polymorphism with serum level and development of pulmonary complications following esophagectomy.

Authors:  Jang-Ming Lee; An-Chi Lo; Shi-Yi Yang; Huei-Shian Tsau; Robert J Chen; Yung-Chie Lee
Journal:  Ann Surg       Date:  2005-04       Impact factor: 12.969

5.  The role of plasminogen activator inhibitor-1 and angiotensin-converting enzyme gene polymorphisms in bronchopulmonary dysplasia.

Authors:  Deniz Anuk Ince; Fatma Belgin Atac; Servet Ozkiraz; Ugur Dilmen; Hande Gulcan; Aylin Tarcan; Namik Ozbek
Journal:  Genet Test Mol Biomarkers       Date:  2010-09-06

6.  ACE deletion polymorphism is associated with a high risk of non-infectious pulmonary complications after stem cell transplantation.

Authors:  Mitsuki Miyamoto; Makoto Onizuka; Shinichiro Machida; Masako Toyosaki; Jun Amaki; Yasuyuki Aoyama; Hidetsugu Kawai; Ai Sato; Naoki Hayama; Yoshiaki Ogawa; Hiroshi Kawada; Kiyoshi Ando
Journal:  Int J Hematol       Date:  2013-12-21       Impact factor: 2.490

7.  Genetic variations in TGFβ1, tPA, and ACE and radiation-induced thoracic toxicities in patients with non-small-cell lung cancer.

Authors:  Shuanghu Tiger Yuan; Vicki L Ellingrod; Matthew Schipper; Kathleen A Stringer; Xuwei Cai; James A Hayman; Jinming Yu; Theodore S Lawrence; Feng-Ming Spring Kong
Journal:  J Thorac Oncol       Date:  2013-02       Impact factor: 15.609

8.  Essential roles for angiotensin receptor AT1a in bleomycin-induced apoptosis and lung fibrosis in mice.

Authors:  Xiaopeng Li; Heather Rayford; Bruce D Uhal
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

9.  Genetic analysis of sporadic and familial interstitial pneumonia.

Authors:  David A Schwartz
Journal:  Proc Am Thorac Soc       Date:  2008-04-15

10.  Angiotensinogen gene G-6A polymorphism influences idiopathic pulmonary fibrosis disease progression.

Authors:  M Molina-Molina; A Xaubet; X Li; A Abdul-Hafez; K Friderici; K Jernigan; W Fu; Q Ding; J Pereda; A Serrano-Mollar; A Casanova; E Rodríguez-Becerra; F Morell; J Ancochea; C Picado; B D Uhal
Journal:  Eur Respir J       Date:  2008-05-28       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.